SpIntellx has officially launched as a computational pathology company applying its proprietary AI technologies to analyze whole slide images based on spatial analytics. Their mission is to develop tools that will improve the accuracy and efficiency of pathologists and to generate predictive data to optimize patient outcomes.

D. Lansing Taylor, Ph.D.
Chairman, Co-Founder

Chakra Chennubhotla, Ph.D.
President, Co-Founder

Michael Becich, M.D., Ph.D.
Co-Founder

Jeffrey Fine, M.D.
Co-Founder

Visit the website for more information: spintellx.com

In the News:

Pitt startup leverages Pittsburgh’s dominant role in new age of autonomy